Form 8-K MANGOCEUTICALS, INC. For: Jul 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq leads Wall St higher as Nvidia eases AI growth concerns
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil prices rise as investors weigh lack of progress in Middle East negotiations
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Revolution Medicines prices RASONQUE at $39,800 per month
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
Mangoceuticals (MGRX) announces termination of Navy Wharf deal
August 4, 2025 9:07 AM EDTAs previously disclosed in that certain Current Report on Form 8-K filed by Mangoceuticals (NASDAQ: MGRX) with the Securities and Exchange Commission (the Commission) on March 25, 2025, on March 24, 2025, we entered into a Master Distribution Agreement (the MSA), with Navy Wharf, Ltd (Navy Wharf). Pursuant to the MSA, the Company was granted the exclusive licensing rights to certain... More
